Published 18 days ago • loading... • Updated 15 days ago

4 States Ask FDA to Lift Rules on Abortion Pill Mifepristone

On Thursday, attorneys general representing four states including those on the East and West Coasts urged the FDA to remove limitations on the abortion medication mifepristone.
They made this request amid the FDA’s planned safety review of mifepristone, which was prompted by a 2022 lawsuit and requests from Robert F. Kennedy Jr. and Senator Josh Hawley.
Mifepristone, used in medication abortions for over 25 years, currently carries rules that attorneys general say hinder many doctors from prescribing it.
Research indicates that serious side effects occur in less than 0.5% of users, and New York’s top legal official has stated there is no scientific or medical justification for imposing stringent limitations on the drug.
The petition suggests removing burdensome rules could improve doctor access to mifepristone and reflects ongoing legal and political debates over abortion medication.

Insights by Ground AI

Does this summary seem wrong?

23 Articles

All

Left

Center

Right

KAKE News

+21 Reposted by 21 other sources

Center

4 States Ask FDA to Lift Rules on Abortion Pill Mifepristone

Key Takeaways

18 days ago

Read Full Article

Medical Xpress

Center

4 states ask FDA to lift rules on abortion pill mifepristone

Attorneys general from four states are asking the U.S. Food and Drug Administration (FDA) to lift restrictions on mifepristone, a pill used in medication abortions.

18 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year